SCHEMBL23488272

SCHEMBL23488272

COc1cc(C(=O)OC[C@H]2OC(C)[C@H](O)[C@@H](O)[C@H]2O)cc(Cl)c1OC(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.43
XDH P47989 2/20 0.42
ALDH1A1 P00352 2/20 0.41
MAPT P10636 1/20 0.41
SELP P16109 2/20 0.40
PTPN1 P18031 1/20 0.39
TYMP P19971 1/20 0.38
SELL P14151 1/20 0.38
NR1I2 O75469 1/20 0.37
CHRM2 P08172 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
ADRA2B P18089 1/20 0.37
SLC6A4 P31645 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
CHRNA4 P43681 1/20 0.37
SLC6A3 Q01959 1/20 0.37
PDE4D Q08499 1/20 0.37
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488431 1.00 TDP1 (0.43) TDP1XDHALDH1A1MAPTSELP
SCHEMBL23488124 0.90 TDP1 (0.49) TDP1XDHALDH1A1MAPTPTPN1
SCHEMBL23488129 0.87 KDM4E (0.46) TDP1XDHALDH1A1MAPTSELP
SCHEMBL23488693 0.87 KDM4E (0.46) TDP1XDHALDH1A1MAPTSELP
SCHEMBL23488426 0.85 XDH (0.43) TDP1XDHALDH1A1MAPTSELP
SCHEMBL23488271 0.85 ALDH1A1 (0.43) TDP1XDHALDH1A1MAPTPTPN1
SCHEMBL23488410 0.84 XDH (0.48) TDP1XDHALDH1A1MAPTPTPN1
SCHEMBL23488609 0.84 XDH (0.48) TDP1XDHALDH1A1MAPTSELP
SCHEMBL23488411 0.84 XDH (0.47) TDP1XDHPTPN1TYMP
SCHEMBL23488290 0.83 TDP1 (0.42) TDP1XDHALDH1A1MAPTSELP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 TDP1 4093/4885XDH 3028/4885ALDH1A1 1627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.